Independent Director · Aktis Oncology, Inc. (AKTS)

J. Michael McGuire director compensation at Aktis Oncology: $70K

Fiscal year 2023 director compensation for J. Michael McGuire at Aktis Oncology, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed October 8, 2024 (DEF 14A). Open the filing on EDGAR.

Free

Get J. Michael McGuire’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track J. Michael McGuire and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Aktis Oncology Director Compensation Table · the one fiscal year held
In US dollars, as Aktis Oncology reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2023$20,875$49,131——$70,006

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Aktis Oncology, Inc. DEF 14A filed October 8, 2024, accession 0001213900-24-086050, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Aktis Oncology, Inc. filed document, accession 0001213900-24-086050. Every figure is read from that document and cited to the page and table it appears in. Filed October 8, 2024.

Get the Aktis Oncology Board Governance Report

$70,006 J. Michael McGuire, FY2023 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of October 8, 2024 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2023

Aktis Oncology pays directors a $140,000 cash retainer.

The rest of the Aktis Oncology board

FY2023 · as the company reported each
DirectorRoleFY2023 total
Arthur E. GeissIndependent Director$81,395
Jeffrey K. McMahonIndependent Director$65,604
Jerry D. NealIndependent Director$105,428
Jill K. FrizzleyIndependent Director$0
Kamran S. CheemaDirector—
Matthew R. KahnIndependent Director$0
Michelle L. PetockIndependent Director$86,900
Steven P. DenBaarsIndependent Director$68,003
Suzanne B. RudyIndependent Director$90,756

The full Aktis Oncology compensation record

free company brief

This page is one director within Aktis Oncology's record. The company brief lists every named executive and director, each linking to their own page.

Order AKTS

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report